Cardiawave

To treat #AorticStenosis, Cardiawave has developed a #NonInvasive therapy using #ultrasound consisting in repairing the #AorticValve. #Medtech #MedicalDevice

[Cardiawave @Cardiawave]

Strong momentum for Valvosoft® in Europe 🚀
In May, 8 additional patients were successfully treated for calcific aortic stenosis across multiple centers in Europe, following Valvosoft®’s CE marking.
Great progress towards routine clinical use!
#MedTech #Cardiology #Innovation

[Cardiawave @Cardiawave]

Cardiawave at #EuroPCR 2026 🚀
2 presentations on our non-invasive ultrasound therapy #Valvosoft
✅CE-marked
✅First patients successfully treated at HEGP (Paris) in April 2026
#Cardiology #MedTech #AorticStenosis

[Cardiawave @Cardiawave]

🇪🇺✅First milestone for Valvosoft®
Last week, 2 patients were successfully treated at #HEGP since its CE marking. More to come as Valvosoft® rolls out across Europe. 🫀 @APHP #MedTech #CEmarked #Valvosoft

[Cardiawave @Cardiawave]

We are saddened by the passing of Professor Robert Levine, MD, a valued member of our Medical Advisory Board 🕊️ A pioneering leader in cardiac imaging at Massachusetts General Hospital and a devoted mentor, he will be missed. May his memory be a blessing. @MassGeneralNews

[Cardiawave @Cardiawave]

@AllianceCoeur❤️ and @CHURouen Rouen are hosting a public awareness day on April 16 with free heart‑valve screenings.
Proud to support this initiative as Valvosoft® recently obtained its CE-Marking. 💙

[Cardiawave @Cardiawave]

🌟Team spirit in action!
We celebrated our CE Marking and turned recycled plastic into donations for #LesPetitsCoeursDeBeurre.
A day full of purpose, creativity, and joy!
#TeamBuilding #SocialImpact #TogetherWeGrow

[Cardiawave @Cardiawave]

Proud to be featured in L’Écho Santé by @MedicenParisRegion 🎙️
At 34:56, F. Ballet calls Cardiawave “a unique technology in the world” and “a story with a promising future.”
Valvosoft® is now CE‑marked — a key milestone for our ultrasound therapy 💙
▶️ https://t.co/czBbIPS4sA

[Cardiawave @Cardiawave]

🎙️ Our CEO Carine Schorochoff joins @CruxOfCardio with @JordanBurgin to discuss non-invasive ultrasound therapy for calcified aortic stenosis.
The full episode is now live — don’t miss it.
https://t.co/HkvRnctwGg
#MedTech #StructuralHeart #AorticStenosis #Innovation2025

[Cardiawave @Cardiawave]

🚀 We will be at #MedInTechs on March 9-10!
Proud to highlight our NIUT non‑invasive ultrasound therapy for severe aortic stenosis, now CE‑marked 💗🔊
Thanks to @BOpEx for hosting us at the Innovation Village! 🙏
#MedInTechs #MedTech #Cardiology #AorticStenosis #CEMarking

[Cardiawave @Cardiawave]

🔎 Access to medical innovation in France is slowing down — impacting patients’ chances.
At Cardiawave, we believe life‑changing cardiovascular technologies should reach patients faster and safely.
🔗 Le Monde op‑ed (FR):
https://t.co/KxpU8f9fcq
#Innovation #Cardiovascular

[Cardiawave @Cardiawave]

🚀 Proud to be featured in @BiotechFinances.
“A lean and specialized team = internalized tasks + targeted CRO support where it added value — costs under control, quality intact.”
#CEmarking achieved for our non‑invasive ultrasound therapy. 💙
🔗https://t.co/rYpsId738m

[Cardiawave @Cardiawave]

We are thrilled to welcome Hardip Thakerar to Cardiawave’s Board 🎉 A proven leader in structural heart innovation, she brings key expertise as we advance our #NIUT therapy for aortic stenosis.
#Cardiawave #MedTech #StructuralHeart #Innovation

[Cardiawave @Cardiawave]

8,000 followers on LinkedIn! 🚀
Thank you for supporting Cardiawave and our mission to bring non‑invasive ultrasound therapy to patients💙
#MedTech #Innovation

[Cardiawave @Cardiawave]

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉
A trusted member of Cardiawave’s Medical Advisory Board, her leadership continues to inspire the cardiology community. 👏
https://t.co/HxvwvQtFbb
#Cardiology #JESFC

[Cardiawave @Cardiawave]

New interview with the @EICScalingClub 🎙️
A big thank you for this high‑quality article highlighting Cardiawave’s mission in non‑invasive cardiovascular innovation.
👉https://t.co/NYg6MMPcnn

[Cardiawave @Cardiawave]

Excited to join #JESFC2026 in Paris (Jan 14–16)!
Save the date:
📅 Jan 14, 3:30 PM: Workshop on aortic stenosis with Prof. Philippe Pibarot & Prof. Emmanuel Messas.📍Room: Maillot
✨Happy New Year!
#Cardiology #Innovation @HopitalPompidou @LavalCanada

[Cardiawave @Cardiawave]

✨2025 was a landmark year for Cardiawave!
✔ CE Marking for #Valvosoft® – first non-invasive ultrasound therapy for sSAS
✔ Key events & partnerships
✔ Leadership milestones
A heartfelt thanks to all & happy holidays! 💙
#MedTech #Innovation #CardiovascularCare

[Cardiawave @Cardiawave]

🎉 Proud moment for Cardiawave! #Valvosoft® has received its #CE Certificate, becoming the world’s 1st non-invasive ultrasound therapy (NIUT) for Severe Symptomatic Aortic Stenosis (#sSAS).
🔗Read our full press release here: https://t.co/UzQBZ2Hu8V💙#CEMarking

[Cardiawave @Cardiawave]

🚨 Catch Cardiawave at #PCRLondonValves2025!
🫀Innovation/CV Pipeline: Nov 16, 14:00, Room A ;
📊Valvosoft® 12-month results: Nov 16, 15:10, Room C – presented by Dr Won Keun Kim.
Let’s shape the future of aortic valve care! 🇬🇧#Valvosoft #InnovationDay

[Cardiawave @Cardiawave]

📢 We are thrilled to welcome Jonathan Freeman as Chairman of the Board at #Cardiawave! His appointment marks a key milestone in our journey to expand MAS indications, launch US clinical trials & kick off EU commercialization. 🔗 https://t.co/eKSZfr4fE1 #MedTech #Innovation